Active — Not RecruitingNot Applicable

Risk Factors for Endometrial Cancer in Black Women

United States59 participantsStarted 2007-07

Plain-language summary

RATIONALE: Learning about the risk factors for endometrial cancer in black women may help the study of endometrial cancer in the future. PURPOSE: This clinical trial is studying risk factors for endometrial cancer in black women.

Who can participate

Age range

21 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Cases * Diagnosed with endometrial cancer within the past year * Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean * Healthy controls * Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean * No history of endometrial or other cancer (except non-melanoma skin cancer) * No prior hysterectomy PATIENT CHARACTERISTICS: * Speak English * No medical condition that would make it difficult to complete the interview PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number and percentage of potential cases and controls approached who are found to be eligible for the study and reasons for being ineligible (including language)

Timeframe: 2 years

Number and percentage of cases and controls approached who sign informed consent

Timeframe: 2 years

Number and percentage of cases and controls who complete each part of the study (main questionnaire, diet questionnaire, saliva/buccal specimen)

Timeframe: 2 years

Proportion of questions with missing data

Timeframe: 2 years

Interviewer's evaluation of interview quality and respondent cooperation

Timeframe: 2 years

Number and percentage of cases who are willing to have tumor specimens used for future research

Timeframe: 2 years

Characteristics of cases and controls (demographics, main risk factors, and use of health care and screening)

Trial details

NCT IDNCT00514254

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-07

View on ClinicalTrials.gov More Endometrial Cancer trials

Who can participate

Age range

21 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number and percentage of potential cases and controls approached who are found to be eligible for the study and reasons for being ineligible (including language)

Timeframe: 2 years

Number and percentage of cases and controls approached who sign informed consent

Timeframe: 2 years

Number and percentage of cases and controls who complete each part of the study (main questionnaire, diet questionnaire, saliva/buccal specimen)

Timeframe: 2 years

Proportion of questions with missing data

Timeframe: 2 years

Interviewer's evaluation of interview quality and respondent cooperation

Timeframe: 2 years

Number and percentage of cases who are willing to have tumor specimens used for future research

Timeframe: 2 years

Characteristics of cases and controls (demographics, main risk factors, and use of health care and screening)